Cargando…

Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration

BACKGROUND: Declining anti-malarial efficacy of artemisinin-based combination therapy, and reduced Plasmodium falciparum susceptibility to individual anti-malarials are being documented across an expanding area of Southeast Asia (SEA). Genotypic markers complement phenotypic studies in assessing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Srimuang, Krongkan, Miotto, Olivo, Lim, Pharath, Fairhurst, Rick M., Kwiatkowski, Dominic P., Woodrow, Charles J., Imwong, Mallika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101715/
https://www.ncbi.nlm.nih.gov/pubmed/27825353
http://dx.doi.org/10.1186/s12936-016-1598-6
_version_ 1782466334262558720
author Srimuang, Krongkan
Miotto, Olivo
Lim, Pharath
Fairhurst, Rick M.
Kwiatkowski, Dominic P.
Woodrow, Charles J.
Imwong, Mallika
author_facet Srimuang, Krongkan
Miotto, Olivo
Lim, Pharath
Fairhurst, Rick M.
Kwiatkowski, Dominic P.
Woodrow, Charles J.
Imwong, Mallika
author_sort Srimuang, Krongkan
collection PubMed
description BACKGROUND: Declining anti-malarial efficacy of artemisinin-based combination therapy, and reduced Plasmodium falciparum susceptibility to individual anti-malarials are being documented across an expanding area of Southeast Asia (SEA). Genotypic markers complement phenotypic studies in assessing the efficacy of individual anti-malarials. METHODS: The markers pfmdr1 and pfcrt were genotyped in parasite samples obtained in 2011–2014 at 14 TRAC (Tracking Resistance to Artemisinin Collaboration) sites in mainland Southeast Asia using a combination of PCR and next-generation sequencing methods. RESULTS: Pfmdr1 amplification, a marker of mefloquine and lumefantrine resistance, was highly prevalent at Mae Sot on the Thailand–Myanmar border (59.8% of isolates) and common (more than 10%) at sites in central Myanmar, eastern Thailand and western Cambodia; however, its prevalence was lower than previously documented in Pailin, western Cambodia. The pfmdr1 Y184F mutation was common, particularly in and around Cambodia, and the F1226Y mutation was found in about half of samples in Mae Sot. The functional significance of these two mutations remains unclear. Other previously documented pfmdr1 mutations were absent or very rare in the region. The pfcrt mutation K76T associated with chloroquine resistance was found in 98.2% of isolates. The CVIET haplotype made up 95% or more of isolates in western SEA while the CVIDT haplotype was common (30–40% of isolates) in north and northeastern Cambodia, southern Laos, and southern Vietnam. CONCLUSIONS: These findings generate cause for concern regarding the mid-term efficacy of artemether–lumefantrine in Myanmar, while the absence of resistance-conferring pfmdr1 mutations and SVMNT pfcrt haplotypes suggests that amodiaquine could be an efficacious component of anti-malarial regimens in SEA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-016-1598-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5101715
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51017152016-11-10 Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration Srimuang, Krongkan Miotto, Olivo Lim, Pharath Fairhurst, Rick M. Kwiatkowski, Dominic P. Woodrow, Charles J. Imwong, Mallika Malar J Research BACKGROUND: Declining anti-malarial efficacy of artemisinin-based combination therapy, and reduced Plasmodium falciparum susceptibility to individual anti-malarials are being documented across an expanding area of Southeast Asia (SEA). Genotypic markers complement phenotypic studies in assessing the efficacy of individual anti-malarials. METHODS: The markers pfmdr1 and pfcrt were genotyped in parasite samples obtained in 2011–2014 at 14 TRAC (Tracking Resistance to Artemisinin Collaboration) sites in mainland Southeast Asia using a combination of PCR and next-generation sequencing methods. RESULTS: Pfmdr1 amplification, a marker of mefloquine and lumefantrine resistance, was highly prevalent at Mae Sot on the Thailand–Myanmar border (59.8% of isolates) and common (more than 10%) at sites in central Myanmar, eastern Thailand and western Cambodia; however, its prevalence was lower than previously documented in Pailin, western Cambodia. The pfmdr1 Y184F mutation was common, particularly in and around Cambodia, and the F1226Y mutation was found in about half of samples in Mae Sot. The functional significance of these two mutations remains unclear. Other previously documented pfmdr1 mutations were absent or very rare in the region. The pfcrt mutation K76T associated with chloroquine resistance was found in 98.2% of isolates. The CVIET haplotype made up 95% or more of isolates in western SEA while the CVIDT haplotype was common (30–40% of isolates) in north and northeastern Cambodia, southern Laos, and southern Vietnam. CONCLUSIONS: These findings generate cause for concern regarding the mid-term efficacy of artemether–lumefantrine in Myanmar, while the absence of resistance-conferring pfmdr1 mutations and SVMNT pfcrt haplotypes suggests that amodiaquine could be an efficacious component of anti-malarial regimens in SEA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-016-1598-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-08 /pmc/articles/PMC5101715/ /pubmed/27825353 http://dx.doi.org/10.1186/s12936-016-1598-6 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Srimuang, Krongkan
Miotto, Olivo
Lim, Pharath
Fairhurst, Rick M.
Kwiatkowski, Dominic P.
Woodrow, Charles J.
Imwong, Mallika
Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
title Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
title_full Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
title_fullStr Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
title_full_unstemmed Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
title_short Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
title_sort analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across southeast asia in the tracking resistance to artemisinin collaboration
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101715/
https://www.ncbi.nlm.nih.gov/pubmed/27825353
http://dx.doi.org/10.1186/s12936-016-1598-6
work_keys_str_mv AT srimuangkrongkan analysisofantimalarialresistancemarkersinpfmdr1andpfcrtacrosssoutheastasiainthetrackingresistancetoartemisinincollaboration
AT miottoolivo analysisofantimalarialresistancemarkersinpfmdr1andpfcrtacrosssoutheastasiainthetrackingresistancetoartemisinincollaboration
AT limpharath analysisofantimalarialresistancemarkersinpfmdr1andpfcrtacrosssoutheastasiainthetrackingresistancetoartemisinincollaboration
AT fairhurstrickm analysisofantimalarialresistancemarkersinpfmdr1andpfcrtacrosssoutheastasiainthetrackingresistancetoartemisinincollaboration
AT kwiatkowskidominicp analysisofantimalarialresistancemarkersinpfmdr1andpfcrtacrosssoutheastasiainthetrackingresistancetoartemisinincollaboration
AT woodrowcharlesj analysisofantimalarialresistancemarkersinpfmdr1andpfcrtacrosssoutheastasiainthetrackingresistancetoartemisinincollaboration
AT imwongmallika analysisofantimalarialresistancemarkersinpfmdr1andpfcrtacrosssoutheastasiainthetrackingresistancetoartemisinincollaboration
AT analysisofantimalarialresistancemarkersinpfmdr1andpfcrtacrosssoutheastasiainthetrackingresistancetoartemisinincollaboration